CURINGINNOS INC. – Trademark Portfolio

Entity Type: 03

CURINGINNOS INC. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 28 (Toys & Sporting Goods) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include IVOLVE. The owner is based in Incheon.

C-206, 5 Seonsuchongongwon-ro,Namdong-gu

Incheon 21582 , KR

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

IVOLVE
IVOLVE
Registered 2022

Trademark Classifications

CURINGINNOS INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

28
Toys & Sporting Goods (1 filing)

Games and playthings; gymnastic and sporting articles; decorations for Christmas trees

Frequently Asked Questions

How many trademarks does CURINGINNOS INC. have?

CURINGINNOS INC. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does CURINGINNOS INC. file in?

CURINGINNOS INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 28 (Toys & Sporting Goods). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are CURINGINNOS INC.'s most well-known trademarks?

CURINGINNOS INC.'s registered trademark portfolio includes well-known marks such as IVOLVE. These are among 1 currently registered trademark in the portfolio.

What is CURINGINNOS INC.'s trademark registration success rate?

CURINGINNOS INC. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.